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ail address: gilles.cauet@horiba.com (G. Cauea b s t r a c tObjective: The technology of magnetic field-assisted immuno-agglutination of super-
paramagnetic particles allows sensitive detection of biomarkers in whole blood. However,
we observed non-specific agglutination (NSA), due to interfering plasma proteins, that
negatively affects C-reactive protein immunoassay. The objective of the study was to
identify the plasma proteins involved and to eliminate these interferences.
Design and methods: Plasma was fractionated by size exclusion HPLC and each fraction
was tested for non-specific agglutination. In addition, plasma proteins bound to magnetic
particles were analyzed by SDS-gel electrophoresis and identified by mass spectrometry.
Results: We found that NSA was due to the binding of some lipoproteins to the particles.
NSA was observed in the presence of purified LDL and VLDL but not HDL. NSA was
mediated by the binding of ApoB100 to magnetic particles through its heparin binding
sites. These interferences could be eliminated by addition of heparin or other polyanions
like dextran sulfate to the assay buffer.
Conclusion: NSA results from the binding of some plasma lipoproteins to magnetic par-
ticles. The use of a polyanion to eliminate these interferences allows the formulation of a
stable reagent.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Magnetic field-assisted agglutination of superparamagnetic particles is a powerful immunoassay method for routine
analyses of biomarkers such as C-reactive protein (CRP) directly in whole blood. The acceleration of particle aggregate
formation induced by the magnetic field make this technology much more sensitive and faster than the widely used latex
agglutination technique. Furthermore, this technology has been successfully integrated in a hematology analyzer combining
simultaneously fast CRP assay and a complete blood count on the same blood sample (patent US2014377771). However, like
other immunological methods, it is subject to non-specific interactions, especially with samples containing high con-
centrations of proteins such as blood and blood derivatives. This represents a serious drawback that can result in significant
and unacceptable performance degradation of the assay.
Non-specific interactions are of different types: interaction of some blood proteins with antibodies used in the assay aser B.V. This is an open access article under the CC BY-NC-ND license
.
L, VLDL, HDL, low density, very low density and high density lipoprotein, respectively; CRP, C-reactive
C, size exclusion chromatography-high performance liquid chromatography; MALDI-TOF, matrix-as-
S, dextran sulfate; ApoA1, ApoB100, apolipoprotein A1 and B100, respectively.
t).
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shown that various blood proteins spontaneously bind to polymeric particles forming a corona [8]. The protein composition
of this corona depends largely on particle surface material, the plasma concentration as well as on/off rate constants for each
protein and hydrophobic/hydrophilic and/or electrostatic interactions [3].
In this article, we describe the identification of plasma proteins responsible for non-specific agglutination in our im-
munoassay and propose a solution to completely eliminate these interactions.2. Materials and methods
2.1. Chemicals
Porcine heparin, purified apolipoproteins, and Lipid Removal Adsorbent were from Sigma (Sigma-Aldrich Chimie, Lyon,
France). Purified lipoproteins were from Interchim (Montlucon, France). CRP-free plasma was from BBI solutions (Le Perray
en Yvelines, France).
2.2. Magnetic agglutination
Carboxyl-modified superparamagnetic particles of 200 nm diameter (Carboxyl Adembeads, Ademtech, Pessac, France)
comprising a magnetic core surrounded by a layer of polymer, were covalently coated with a goat polyclonal antibody
directed against human C-reactive protein (Meridian Life Sciences, Memphis, TN, USA) using a carbodiimide coupling
chemistry. Magnetic agglutination assay was performed as previously described [4]. Briefly, a homogeneous magnetic field
generated by an electromagnet is applied to the reaction medium for 7 s at 20 mT. Then the magnetic field is turned off and
the optical density is measured at 650 nm after 3 s of relaxation. The signal is expressed as the difference in optical density
before and after application of the field. For routine CRP assay, blood samples were first diluted in Horiba lysis buffer (ABX
Eosinofix, Horiba Medical, Montpellier, France). An aliquot was then taken and mixed with the assay buffer (glycine 50 mM
pH8.5) and magnetic particles (0.04%). The final sample dilution factor was 1500.
2.3. SDS-PAGE analysis of proteins bound to magnetic particles
Magnetic particles were incubated either with 100 mL of CRP-free human plasma or purified lipoproteins for 30 min at
25 °C, washed, re-suspended in non-reducing SDS buffer, and heated at 95 °C for 5 min. SDS-PAGE analysis of the super-
natant was performed in preformed SDS-polyacrylamide gels (Biorad, Hercules, CA, USA). Proteins were stained with
Coomassie Blue G250.
2.4. In-gel trypsin digestion and mass spectrometry
In-gel trypsin digestion was carried out essentially as described previously [9]. Briefly, following SDS-PAGE, stained
protein bands were cut out from the gel and digested with sequence-grade modified bovine trypsin (Promega Corporation,
Madison, WI, USA). The peptides generated were subsequently extracted and submitted to mass spectrometry on a MALDI-
TOF instrument (Ultraflex, Bruker Corporation, Billerica, MA, USA). Monoisotopic peptide masses obtained were used for
protein identification by database searching.
2.5. Size exclusion HPLC
Human plasma (100 mL) was fractionated by SEC-HPLC on a Yarra 3 m SEC-3000 column (3007.8 mm, Phenomenex,
Macclesfield, UK) at 1 ml/min in 50 mM phosphate, NaCl 300 mM, pH 6.8. UV absorption was monitored at 230 nm. The
column was calibrated using molecular weight standards (Biorad).
2.6. Cholesterol assay
The presence of cholesterol bound to magnetic particles after incubation with human plasma was determined by an enzy-
matic assay using ABX Cholesterol CP (Horiba Medical). Superparamagnetic particles (SMP) (0.4%) were incubated with a pool of
human plasma or 0.9% saline solution for 15 min at room temperature, and then washed with a glycine buffer (50 mM, pH 8.5).
Washed particles were re-suspended directly in cholesterol assay reagent and incubated at 37 °C for 7 min. Absorbance at
505 nm was measured on the supernatant. In some experiments, dextran sulfate (DXS; 1 g/L) was added to the plasma sample.
2.7. Other assays
Plasma cholesterol, ApoA1, ApoB100 and CRP were determined on a ABX Pentra 400 automatic analyzer (HORIBA
Medical, Montpellier, France) using dedicated reagents.
Fig. 1. SDS-PAGE analysis (12%), under non-reducing conditions, of proteins bound to magnetic particles: (1) molecular weight standards (reduced);
(2) purified HDL; (3) proteins bound to SMP after incubation with human CRP-depleted plasma. The protein band at about 50 kDa co-migrated with human
serum albumin; (4) proteins bound to SMP after incubation with purified HDL.
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3.1. Lipoproteins are involved in non-specific agglutination of magnetic particles
Magnetic field-assisted agglutination of superparamagnetic particles (SMP) is the basis of a new homogeneous im-
munoassay with high sensitivity and reduced analysis time [1]. During the development of a C-reactive protein im-
munoassay in whole blood based on this technology, we observed significant non-specific agglutination (NSA) of SMP when
submitted to a magnetic field despite an important sample dilution.
NSA was observed independently of the animal origin of the antibody immobilized on SMP. It was also observed with
SMP not grafted with antibodies. This ruled out possible involvement of heterophile antibodies or rheumatoid factor, but
seemed directly related to the SMP surface itself. It has been shown that numerous blood proteins were able to bind to the
surface of the nanoparticles forming a corona and that the protein composition of this corona depended on plasma dilution
[2]. Thus, it was hypothesized that some of these particle binders could have been involved in NSA.
It is well known that many plasma proteins such as albumin and immunoglobulins bind to polymer particles. However,
we found that none of these proteins were capable of inducing NSA. In order to know which proteins could bind to SMP
surface, grafted SMP were pre-incubated with human CRP-depleted plasma. After washing, particles were re-dispersed in a
denaturing but non-reducing sample buffer in order not to release immobilized antibody fragments. The supernatant was
then analyzed by SDS-PAGE (Fig. 1). As well as human serum albumin, a prominent protein band at about 28 kDa was found
associated with the particles. This band was excised from the gel, and digested with trypsin. Trypsin-generated peptides
were eluted from the gel and submitted to MALDI-TOF mass spectrometry. The peptide mass profile obtained was un-
ambiguously attributed to ApoA1 (data not shown). The same protein band was found when particles were incubated withFig. 2. Fractionation of human plasma by SEC-HPLC. Human plasma (100 mL) was loaded on the column and fraction (0.25 mL) were tested for NSA ().
Purified lipoproteins were analyzed under the same conditions (lines marked VLDL, LDL and HDL).
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magnetic field in the presence of different amounts of purified ApoA1. However, NSAwas not observed which demonstrated
that ApoA1 was not responsible for NSA.
However, we observed that a pool of plasma previously delipidated after treatment with LRA (lipid removal adsorbent)
was no longer capable of inducing any agglutination of SMP under a field. This result strongly suggested the involvement of
lipoproteins in non-specific agglutination of SMP. ApoA1 is the major protein constituent of HDL and we theorized that HDL
instead of isolated ApoA1 was responsible for NSA. However, purified HDL was not capable of inducing any agglutination of
SMP when submitted to a magnetic field. This result indicated that other lipoproteins were likely to be involved in NSA.
3.2. Lipoproteins other than HDL are responsible for NSA
In order to further confirm this hypothesis, a pool of CRP-depleted human plasma was submitted to size exclusion
chromatography (SEC-HPLC) (Fig. 2). Fractions (0.25 ml) were collected and tested for NSA on grafted SMP under a magnetic
field. We found that fractions inducing NSA were eluted as a double peak corresponding to high molecular compounds of
more than 700 kDa. Thus if lipoproteins are involved in NSA, this points to high molecular weight structures such as LDL or
VLDL. In order to identify which type of lipoproteins was responsible for NSA, purified VLDL, LDL and HDL were successively
loaded on the SEC-HPLC column. We found that the double peak inducing NSA was eluted with retention times corre-
sponding to those of VLDL and LDL. The small peak present at RT¼9 min, was due to residual amounts of pentameric human
CRP still present in the CRP-depleted plasma used.
The role of LDL in NSA was further confirmed by using purified human LDL as the sample in a magnetic agglutination
assay. The results clearly showed that LDL induced NSA under a field in a dose-dependent manner (Fig. 3). The curve reached
a maximum and then slowly decreased. This behavior resembled a hook effect and suggested direct binding of LDL to the
particles resulting in the formation of aggregates. As the LDL concentration increased, binding sites were progressively
saturated which resulted in a reduction of aggregate formation. Indeed, it has already been shown that complete lipo-
proteins could bind to polymer particles [5]. Thus, if whole LDL particles could bind to SMP, we should find the main
components of LDL (i.e. ApoB100 and such as cholesterol) associated with the particles.
To address this question, grafted magnetic particles were incubated with purified LDL in buffer, and subsequently washed
several times to remove any loosely-bound material. A fraction of these particles was incubated with a non-reducing SDS
denaturing buffer. The supernatant was analyzed by SDS-PAGE. The protein profile obtained showed a high molecular
weight band which co-migrated with purified human ApoB100 (Fig. 4).
In order to determine whether complete LDL was bound to SMP, the remainder of the washed particles were assayed for
cholesterol using a routine enzymatic assay. The absorbance obtained was significantly higher when SMP were incubated
with LDL than with physiological saline, which indicated that cholesterol was bound to SMP (Table 1). These results con-
firmed that not only apoB100 but intact LDL was able to bind to magnetic particles. The binding of LDL probably induced
agglutination of SMP by forming bridges between particles when submitted to a magnetic field.
3.3. Heparin eliminates NSA
Non-specific agglutination of SMP could be significantly reduced by increasing the ionic strength of the assay. This resultLDL (mg/mL) 
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Fig. 3. Dose–response curve as a function of purified LDL concentration in our magnetic agglutination assay. SMP (0.04%) were mixed with various
concentrations of purified human LDL and submitted to a magnetic field under the conditions described in Section 2.
Fig. 4. SDS-PAGE analysis under non-reducing conditions of proteins bound to magnetic particles: (1) molecular weight standards (reduced); (2) purified
ApoB100; (3) proteins bound to magnetic particles incubated with purified LDL.
Table 1
Cholesterol binding to SMP. SMP (0.4%) were incubated either with a pool of human plasma (with or without 1 g/L of dextran sulfate, DXS) or 0.9% NaCl.
Cholesterol was assayed enzymatically directly on washed particles. Optical density change is shown (ΔOD505 nm).
ΔOD505 nm
SMPþ0.9% NaCl 0.126
SMPþHuman plasma 0.203
SMPþhuman plasmaþDXS 0.131
Heparin (mg/L)
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Fig. 5. Effect of heparin on NSA. Non-grafted SMP (0.04%) were mixed with a pool of human plasma diluted 1500 times in buffer in the presence of
increasing amounts of porcine heparin and submitted to a magnetic field.
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the net charge of both SMP and LDL is negative [6]. This normally should have prevented any electrostatic interactions
between SMP and LDL. However, it has been already noted that effective charge is not the major driving force regulating
particle–proteins interaction [12]. On the other hand, it has been shown that apoB100, which is the major protein
Table 2
Effect of heparin (0.5 g/L) on CRP measured with SMP immunoassay in two human plasma samples with different level of lipoproteins as determined by
cholesterol and apolipoproteins concentrations.
Plasma 1 Plasma 2
Cholesterol (mM)a 7.03 3.74
ApoA1 (g/L)a 1.62 1.25
ApoB100 (g/L)a 1.55 0.73
CRP (mg/L)a 6.16 0.27
CRP (mg/L) SMP without heparin 17.76 6.03
CRP (mg/L) SMP with heparin 5.73 0.22
a Measured on a ABX Pentra 400 automatic analyzer.
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recognized as heparin binding sites [13]. Thus, the possibility that binding between SMP and LDL could have occurred
through these heparin binding sites was investigated. If so, heparin should inhibit interactions between SMP and LDL.
Indeed, we found that addition of heparin significantly reduced non-specific agglutination of SMP in a pool of human
plasma (Fig. 5). This result strongly suggested the involvement of ApoB100 heparin binding sites in non-specific aggluti-
nation of SMP under a field in the presence of plasma. This inhibitory effect of heparin on NSA could also be obtained when
heparin was replaced by other polyanions like dextran sulfate. This is consistent with the finding that dextran sulfate
prevented cholesterol from binding to the particles (Table 1).
The effect of heparin on NSA was further confirmed with native plasma samples with different level of lipoproteins (as
reflected by cholesterol and apolipoproteins concentrations). We compared CRP concentrations obtained in the presence or
absence of heparin in our SMP immunoassay with CRP concentrations measured on a ABX Pentra 400 automatic analyzer
(Table 2). We found that, without heparin, CRP concentrations were substantially overestimated whereas in the presence of
heparin, CRP concentrations obtained were very close to those measured by the independent method. We obtained com-
parable results when heparin was replaced by dextran sulfate.
Thus both heparin and dextran sulfate are capable of eliminating interference due to lipoproteins independently of their
plasma level.
3.4. ApoB100 is involved in NSA
To further confirm the role of basic clusters of ApoB100 in NSA, lysine residues were indirectly modified by oxidation of
LDL phospholipids. It has been shown that lipoprotein phospholipids can undergo oxidation, and that oxidation products are
capable of modifying lysine residues, resulting in loss of the positive charge [10]. These modifications were found to in-
terfere, for example, with the ability of LDL to bind to negatively-charged glucosaminoglycan chains of proteoglycan [7]. This
oxidation process, which is quite slow, could be accelerated by using divalent metals like Cu2þ . Accordingly, LDL was in-
cubated with 5 mM copper chloride at room temperature. Aliquots were taken at various time intervals and tested for NSA.
Copper-induced oxidation of LDL resulted in a progressive reduction of NSA (not shown). This result confirmed that binding
of LDL to SMP was due to ionic interactions between heparin binding sites on ApoB100 and negatively charged SMP.
Although it was demonstrated that LDL was involved in NSA, VLDL contribution to NSA cannot be excluded since (1) part
of NSA co-eluted with VLDL on SEC-HPLC and (2) ApoB100 is also present on this lipoprotein.4. Conclusion
The incidence of NSA on SMP in our immunoassay was eliminated by introducing a polyanion such as heparin in the
assay buffer. Other polyanions (dextran) were equally efficient in reducing NSA. Although these non-specific interactions
could also be eliminated by increasing the buffer ionic strength, we found that too high a salt concentration induced a
progressive self-agglutination of magnetic particles upon storage which required separation of the assay buffer and the
particle suspension. In contrast, addition of heparin or dextran sulfate to the assay buffer allowed the formulation of a stable
single reagent consisting of magnetic particles suspended in the assay buffer. The use of a single reagent is particularly
important for assay automation in terms of improved analysis time and reduced cost per test.Acknowledgment
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